Today: 12 June 2026
FreeCast Rallies on DIRECTV Deal, But Risks Remain for CAST
12 June 2026
2 mins read

FreeCast Rallies on DIRECTV Deal, But Risks Remain for CAST

Orlando, Florida, June 12, 2026, 14:06 (EDT)

  • FreeCast shares surged Friday as the company said it was broadening its DIRECTV partnership to cover both residential and Platform-as-a-Service partner channels.
  • The rally saw wild swings and several volatility pauses. The company’s most recent filing still reports big losses and flags a going-concern risk.

FreeCast, Inc. (NASDAQ: CAST) shot up as much as 147% Friday, with shares last at $1.59. The stock saw heavy action in a range from $0.5452 to $1.93, and close to 148 million shares changed hands. The rally came a day after FreeCast said it can offer DIRECTV services through its direct-to-consumer residential business and its Platform-as-a-Service ecosystem. PaaS is software infrastructure sold to other brands. Business Wire Benzinga said Friday’s jump was tied to investor reaction to the DIRECTV move.

CAST is in focus as traders see the DIRECTV tie-up as a possible revenue boost. FreeCast said the expanded deal goes past just selling DIRECTV in homes and apartments, now letting it offer services through partners like telecoms, broadband firms, wireless companies, property owners, hotels, cities, broadcasters and big enterprise clients. Business Wire CEO William Mobley said the new phase is “more than a distribution agreement” and could see DIRECTV added to FreeCast’s residential sales and PaaS push. Business Wire

Bulls see a clear path: FreeCast is pitching itself as a streaming infrastructure layer, beyond just a consumer app. The company says its platform can handle live TV, FAST channels (free ad-supported streaming), premium streamers, local shows, ads, commerce, and subscriber management, all inside partner-branded setups. Business Wire If DIRECTV subscriptions move fast through these partners, recurring revenue — not one-off sales — could be on the table for investors.

The bear case can’t be ignored. FreeCast reported revenue of just $92,909 for the quarter ended March 31, 2026, with a net loss of $4.53 million for the period and a $10.18 million net loss across the first nine months of its fiscal year. SEC In the same filing, the company reported $119,302 in cash as of March 31. Management flagged “substantial doubt” about its ability to keep operating, citing recurring losses and the need to raise more capital. SEC

CAST’s trading on Friday wasn’t just about momentum—there were real risk signs. The Cboe’s halt log shows CAST hit multiple volatility pauses on June 12, with the stock halted for five-minute stretches after sudden spikes; those stops are triggered by LULD rules that try to tamp down wild price swings. Cboe Global Markets Data from Investing.com had the shares still well off the $33 52-week high, making clear how much of the value has disappeared since the direct listing in March.

Investors now need to see if the DIRECTV expansion is leading to real numbers—revenue, new subscribers, actual partner deployments or better cash flow. FreeCast said more partnerships and integrations could be on the way, but in its latest update didn’t share terms, targets or subscriber numbers. Business Wire The next set of results, which will include the June 30 fiscal year end, could show if the company’s recent platform moves are starting to close the gap on losses and cash needs.

Broker coverage on CAST is sparse, making the valuation tough to pin down. StockAnalysis shows just one analyst rating: Buy, with a $6 target over 12 months. Maxim started covering the name seven weeks back, also with a Buy and a $6 target, according to StockAnalysis. StockAnalysis Those calls back up the bull case, but don’t clear up the funding, dilution and execution issues flagged in FreeCast’s own filing.

CAST is showing risk over value after today’s review of the facts. DIRECTV is a legitimate catalyst, and Friday’s big rally highlights how jumpy the stock gets on any news around recurring revenue. But heavy intraday swings, small revenue, big losses, tight cash and clear going-concern warnings all stand out. This is a stock for investors who can handle high risk and want clear signs of monetization. Those who want stable fundamentals probably won’t find it here.

Stock Market Today

  • Nucor Stock Up 124% in One Year - Is It Still Undervalued?
    June 12, 2026, 2:56 PM EDT. Nucor Corporation (NUE) has surged 123.6% over the past year, closing at $260.90. Despite this rally, a Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by approximately 34.2%, with an intrinsic value estimated at $396.42 per share. The DCF model projects future free cash flows growing from $656.4 million recently to $5.8 billion by 2030. This implies potential for further gains, contrasting with a current valuation score of 3 out of 6. Investors are weighing Nucor's strong performance in the metals and mining sector against market risks and growth expectations, considering valuation alongside its price-to-earnings ratio, a common metric for assessing stock value relative to earnings.

Latest articles

FreeCast Rallies on DIRECTV Deal, But Risks Remain for CAST

FreeCast Rallies on DIRECTV Deal, But Risks Remain for CAST

12 June 2026
FreeCast (NASDAQ: CAST) soared 147% to $1.59 on nearly 148 million shares after expanding its DIRECTV partnership to residential and Platform-as-a-Service channels, but the surge came amid extreme volatility, ongoing heavy losses, just $119,302 in cash, and a going-concern warning, with no new financial terms or subscriber targets disclosed.
Cuprina jumps after Nasdaq compliance update, but risks remain

Cuprina jumps after Nasdaq compliance update, but risks remain

12 June 2026
CUPR soared 74% to $4.20 after Cuprina said Nasdaq confirmed it had regained compliance with minimum bid price rules, removing immediate delisting risk following a 1-for-8 share consolidation; Friday’s rally reflects relief over trading continuity, but with 2025 revenue at just US$38,789 and net loss at US$3.63 million, investors now await proof of commercial traction in chronic wound care markets.
Cuprina jumps after Nasdaq compliance update, but risks remain
Previous Story

Cuprina jumps after Nasdaq compliance update, but risks remain

Go toTop